Shanghai, Shanghai, China In 2010 was created Hermed Capital, which is appeared as VC. The main department of described VC is located in the Shanghai. The venture was found in Asia in China.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Hermed Capital, startups are often financed by Safeguard Scientifics, Roche Venture Fund, Pfizer Venture Investments. The meaningful sponsors for the fund in investment in the same round are Viventures, Ping An Ventures, Vivo Capital. In the next rounds fund is usually obtained by Viventures, Varian, Sabby Management.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Epic Sciences, Spineology, Spineology. Among the most successful fund investment fields, there are Medical Device, Pharmaceutical. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
The top activity for fund was in 2017. This Hermed Capital works on 16 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 55 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| Chuangdong Investment Consulting | Beijing, Beijing, China |
| Hengrui Zhanye Touzi | China, Guangdong, Shenzhen |
| Hooot | China, Hangzhou, Zhejiang |
| ICONYC labs | New York, New York, United States |
| Ionics | Laguna, Masbate, Philippines |
| Prairie Gold | Bloomington, Illinois, United States |
| Reformation Partners | New York, New York, United States |
| Virscend Education Company | Chengdu, China, Sichuan |
| Woshi Investment | China, Shanghai |
| Yangtze River Delta Collaborative Advantage Industry Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $40M | 31 Jul 2019 | Qingyang District, Sichuan, China | |||
Prognos Health | $20M | 27 Nov 2017 | New York, New York, United States | ||
Aadi Bioscience | $23M | 08 May 2017 | Los Angeles, California, United States | ||
Ativa Medical | $15M | 17 Sep 2015 | Saint Paul, Minnesota, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $40M | 31 Jul 2019 | Qingyang District, Sichuan, China | |||
Prognos Health | $20M | 27 Nov 2017 | New York, New York, United States | ||
Aadi Bioscience | $23M | 08 May 2017 | Los Angeles, California, United States | ||
Ativa Medical | $15M | 17 Sep 2015 | Saint Paul, Minnesota, United States |
